Consequences of Noradrenergic Degeneration in the Novel TgF344-AD Rat Model

新型 TgF344-AD 大鼠模型中去甲肾上腺素能变性的后果

基本信息

  • 批准号:
    10581841
  • 负责人:
  • 金额:
    $ 58.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-15 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Noradrenergic (NA) input to hippocampus from locus coeruleus (LC), the sole supplier of NA innervation to forebrain, is required for acquisition and consolidation of spatial learning and memory and contextual fear behavior. The dentate gyrus (DG) contains the highest NA content, greatest NA fiber density, and largest expression of β1-and β2-adrenergic receptors (ARs) in the hippocampal formation, consistent with DG being a key region of modulatory control by LC. There is a rich literature dating back to the mid 1980’s showing a critical role for β-ARs in facilitating induction of both LTP and LTD at DG synapses depending upon the saliency of the experience. This heightened plasticity occurs simultaneous with heightened learning and memory, and both are prevented by loss of NA innervation or pharmacological blockade of β-ARs. Importantly, the LC in females has a larger volume, LC neurons have greater dendritic arbors, and at proestrus, when plasma estradiol levels are the highest, NA neuronal activity is decreased. The LC is the first brain region damaged in Alzheimer’s disease (AD), due to accumulation of hyper- phosphorylated tau (p-tau). The consequence of this pathology is greatly under-appreciated since transgenic AD mouse models do not recapitulate this feature of human disease. Fortunately, the novel TgF344-AD rat model has significant p-tau accumulation in LC and NA axon loss in hippocampus, permitting detailed studies of LC and NA system dysfunction on hippocampal synaptic transmission and learning and memory. Clearly, identifying strategies to prevent p-tau accumulation and LC damage is critical. The post-translational modification, O- GlcNAcylation, has been shown to do just this through competition with phosphorylation at key serine residues on p-tau that cause its accumulation. Using brain slice electrophysiology, we reported pathologically heightened LTP at medial perforant path synapses in dentate gyrus prior to CA1 synapses in both sexes. In recent data, we find heightened potentiation at medial perforant path synapses following pharmacological activation of β-ARs. This upregulation of β-AR function in the context NA fiber loss likely drives the heightened LTP and masks deficits in learning and memory early in the disease. The current proposal will test the hypothesis that hippocampal noradrenergic function in AD is impaired via aberrant excitability of LC-NA cells caused by progressive p-tau accumulation and through NA denervation, both of which will be worse in ovariectomized females and protected by O-GlcNAcylation. We will use a combination of electrophysiology in hippocampus and locus coeruleus, hippocampus-dependent behavior, pharmacology, biochemistry, and O-GlcNAc biology to test this innovative hypothesis. Outcomes will shed new light on the role of LC damage in AD, and will lay the ground work for therapeutic strategies targeting the LC and perhaps O-GlcNAcylation.
项目摘要 NA神经支配的唯一供应商 前脑是获得和巩固空间学习和记忆以及上下文恐惧所必需的 行为。齿状回(DG)包含最高的Na含量,最大的Na纤维密度和最大的 海马形成中β1和β2-肾上腺素能受体(ARS)的表达,与DG为A LC的调节控制的关键区域。有一本丰富的文献可以追溯到1980年代中期,显示了关键 β-AR在DG突触中支持LTP和LTD诱导LTP和LTD的作用,取决于显着性 经验。这种增强的可塑性同时发生了学习和记忆的增强,两者都是 通过失去NA神经或药物阻断β-AR的阻止。重要的是,女性的LC有 较大的LC神经元具有更大的树突状乔木,而在血浆雌二醇水平为 最高的NA神经元活性降低。 LC是阿尔茨海默氏病(AD)中第一个脑部区域,由于高度积累 磷酸化的tau(p-tau)。由于转基因广告,这种病理的结果被低估了 小鼠模型不会概括人类疾病的这一特征。幸运的是,新型TGF344-AD大鼠模型 在海马中,LC和Na轴突损失有明显的P-TAU积累,允许对LC进行详细研究 和NA系统功能障碍在海马合成传播,学习和记忆方面。显然,识别 防止P-TAU积累和LC损伤的策略至关重要。翻译后修改,o- Glcnacylation已被证明通过在关键串行保留下与磷酸化的竞争来做到这一点 在p-tau上导致其积累。据报道,使用大脑切片电生理学,我们提高了 在两性中,在Ca1突触之前,在齿状回的内侧穿孔路径突触中的LTP。在最近的数据中,我们 在药物激活β-AR的药物激活后,发现中值穿孔路径突触的潜力提高。 β-ar功能在上下文中的这种上调NA纤维损失可能会驱动增强的LTP和掩模 疾病早期学习和记忆的缺陷。当前的提议将检验以下假设 AD中海马去甲肾上腺素能的功能受到了由LC-NA细胞的异常刺激而受损 进行性p-tau积累和通过NA神经支配,这两者在卵巢切除术中都会更糟 女性,受O-Glcnacylation的保护。我们将在海马和 基因座,海马依赖性行为,药理学,生物化学和O-GLCNAC生物学测试 这个创新的假设。成果将为液晶损伤在AD中的作用提供新的启示,并将铺设地面 针对针对LC甚至O-Glcnacylation的治疗策略的工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LORI Lynn MCMAHON其他文献

LORI Lynn MCMAHON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LORI Lynn MCMAHON', 18)}}的其他基金

Consequences of Noradrenergic Degeneration in the Novel TgF344-AD Rat Model
新型 TgF344-AD 大鼠模型中去甲肾上腺素能变性的后果
  • 批准号:
    10621852
  • 财政年份:
    2020
  • 资助金额:
    $ 58.8万
  • 项目类别:
Impact of estrogen loss and replacement on GluN2B containing NMDARs, synaptic plasticity, and learning and memory in females using a novel transgenic rat model of Alzheimer’s Disease
使用新型阿尔茨海默病转基因大鼠模型,研究雌激素损失和替代对含有 NMDAR 的 GluN2B、突触可塑性以及女性学习和记忆的影响
  • 批准号:
    9128361
  • 财政年份:
    2016
  • 资助金额:
    $ 58.8万
  • 项目类别:
Estrogen and hippocampal plasticity
雌激素和海马可塑性
  • 批准号:
    7849770
  • 财政年份:
    2008
  • 资助金额:
    $ 58.8万
  • 项目类别:
Estrogen and hippocampal plasticity
雌激素和海马可塑性
  • 批准号:
    8109411
  • 财政年份:
    2008
  • 资助金额:
    $ 58.8万
  • 项目类别:
Estrogen and hippocampal plasticity
雌激素和海马可塑性
  • 批准号:
    8257977
  • 财政年份:
    2008
  • 资助金额:
    $ 58.8万
  • 项目类别:
Estrogen and hippocampal plasticity
雌激素和海马可塑性
  • 批准号:
    7643164
  • 财政年份:
    2008
  • 资助金额:
    $ 58.8万
  • 项目类别:
Muscarinic receptor induced LTD in rat hippocampus
毒蕈碱受体诱导大鼠海马LTD
  • 批准号:
    8205782
  • 财政年份:
    2004
  • 资助金额:
    $ 58.8万
  • 项目类别:
Muscarinic receptor induced LTD in rat hippocampus
毒蕈碱受体诱导大鼠海马LTD
  • 批准号:
    8850751
  • 财政年份:
    2004
  • 资助金额:
    $ 58.8万
  • 项目类别:
Muscarinic Receptor Induced LTD in Rat Hippocampus
大鼠海马毒蕈碱受体诱导的LTD
  • 批准号:
    6838750
  • 财政年份:
    2004
  • 资助金额:
    $ 58.8万
  • 项目类别:
Muscarinic receptor induced LTD in rat hippocampus
毒蕈碱受体诱导大鼠海马LTD
  • 批准号:
    8318052
  • 财政年份:
    2004
  • 资助金额:
    $ 58.8万
  • 项目类别:

相似海外基金

Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
  • 批准号:
    10718104
  • 财政年份:
    2023
  • 资助金额:
    $ 58.8万
  • 项目类别:
Consequences of Noradrenergic Degeneration in the Novel TgF344-AD Rat Model
新型 TgF344-AD 大鼠模型中去甲肾上腺素能变性的后果
  • 批准号:
    10621852
  • 财政年份:
    2020
  • 资助金额:
    $ 58.8万
  • 项目类别:
Calcium and the Pathophysiology of Neurodegenerative Disorders
钙与神经退行性疾病的病理生理学
  • 批准号:
    10052965
  • 财政年份:
    2020
  • 资助金额:
    $ 58.8万
  • 项目类别:
Neuromodulatory mechanisms underlying vagus nerve stimulation therapy for Alzheimer's disease
迷走神经刺激疗法治疗阿尔茨海默病的神经调节机制
  • 批准号:
    10117356
  • 财政年份:
    2019
  • 资助金额:
    $ 58.8万
  • 项目类别:
Discovery of functionally selective Alzheimer's disease therapeutics
发现功能选择性阿尔茨海默病疗法
  • 批准号:
    10204720
  • 财政年份:
    2017
  • 资助金额:
    $ 58.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了